A systematic review and economic model of the clinical effectiveness and cost-effectiveness of docetaxel in combination with prednisone or prednisolone for the treatment of hormone-refractory metastatic prostate cancer.

Ros Collins; E Fenwick; R Trowman; R Perard; G Norman; K Light; A Birtle; A Palmer; R Riemsma

A systematic review and economic model of the clinical effectiveness and cost-effectiveness of docetaxel in combination with prednisone or prednisolone for the treatment of hormone-refractory metastatic prostate cancer.

Ros Collins, E Fenwick, R Trowman, R Perard, G Norman, K Light, A Birtle, A Palmer, R Riemsma

Centre for Reviews and Dissemination

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	1-202
Number of pages	202
Journal	Health Technology Assessment
Volume	11(20):
Publication status	Published - 2007

Access to Document

http://www.hta.ac.uk/fullmono/mon1102.pdf

Cite this

Collins, R., Fenwick, E., Trowman, R., Perard, R., Norman, G., Light, K., Birtle, A., Palmer, A., & Riemsma, R. (2007). A systematic review and economic model of the clinical effectiveness and cost-effectiveness of docetaxel in combination with prednisone or prednisolone for the treatment of hormone-refractory metastatic prostate cancer. Health Technology Assessment, 11(20):, 1-202. http://www.hta.ac.uk/fullmono/mon1102.pdf

@article{0073d14d0c814cd0b16c3736605370b3,

title = "A systematic review and economic model of the clinical effectiveness and cost-effectiveness of docetaxel in combination with prednisone or prednisolone for the treatment of hormone-refractory metastatic prostate cancer.",

author = "Ros Collins and E Fenwick and R Trowman and R Perard and G Norman and K Light and A Birtle and A Palmer and R Riemsma",

year = "2007",

language = "English",

volume = "11(20):",

pages = "1--202",

journal = "Health Technology Assessment",

issn = "2046-4924",

publisher = "NHS National Institute for Health Research",

}

Collins, R, Fenwick, E, Trowman, R, Perard, R, Norman, G, Light, K, Birtle, A, Palmer, A & Riemsma, R 2007, 'A systematic review and economic model of the clinical effectiveness and cost-effectiveness of docetaxel in combination with prednisone or prednisolone for the treatment of hormone-refractory metastatic prostate cancer.', Health Technology Assessment, vol. 11(20):, pp. 1-202. <http://www.hta.ac.uk/fullmono/mon1102.pdf>

A systematic review and economic model of the clinical effectiveness and cost-effectiveness of docetaxel in combination with prednisone or prednisolone for the treatment of hormone-refractory metastatic prostate cancer. / Collins, Ros; Fenwick, E; Trowman, R et al.
In: Health Technology Assessment, Vol. 11(20):, 2007, p. 1-202.

Research output: Contribution to journal › Article › peer-review

TY - JOUR

T1 - A systematic review and economic model of the clinical effectiveness and cost-effectiveness of docetaxel in combination with prednisone or prednisolone for the treatment of hormone-refractory metastatic prostate cancer.

AU - Collins, Ros

AU - Fenwick, E

AU - Trowman, R

AU - Perard, R

AU - Norman, G

AU - Light, K

AU - Birtle, A

AU - Palmer, A

AU - Riemsma, R

PY - 2007

Y1 - 2007

M3 - Article

SN - 2046-4924

VL - 11(20):

SP - 1

EP - 202

JO - Health Technology Assessment

JF - Health Technology Assessment

ER -